Indian pharmaceutical industry, also known as ‘Pharmacy of the world’ is one of those sectors which have geared-up significantly in the post-pandemic era. Being ranked 3rd in pharmaceutical production, both in terms of value and volume, it imparts innovative drugs and creating value through innovative technologies including cell and gene therapy, new molecular or biological entities and precision (customized) medicines in a cost-effective manner. And this has paved the way for India to become a Medical tourism hub world-wide.

Big thanks to Big Data Analytics, Data Science, Blockchain and Artificial Intelligence (AI) as they have completely changed the outlook of this industry and have helped it to undergo a huge digital transformation. The infusion of strong academic and unmatched talent from both digital and life sciences background is the core factor which has vitally increased the capabilities and has stimulated the growth of this sector, from development of new drugs to sustainable manufacturing.

Led by disruptive technologies and emerging trends like artificial intelligence, robotics, precision medicine or patient design, the Indian pharma industry is expected to grow at a compound annual growth rate (CAGR) of 11.34 percent from 2021 to 2028 with the emergence of latest technologies, cost-effective, and more efficient manufacturing approaches as per the published market research report by Grand View...